Intravenous beta2‐agonists for acute asthma in the emergency department
Beta2‐agonist drugs form one of the mainstays of the treatment of acute severe asthma. They may be given by the inhaled or intravenous route. This review examined all the randomised controlled trials of the use of intravenous beta2‐agonists in acute asthma and found no evidence to support its use. 
